Anniversary Milestone Highlights Expanded Manufacturing Capacity, Stronger Asia-Pacific Presence, and Measurable ...

Analysts have provided the following ratings for Cytek Biosciences (NASDAQ:CTKB) within the last quarter: In the last 3 months, 4 analysts have offered 12-month price targets for Cytek Biosciences.

FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek ® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial ...

At this time, I would like to welcome everyone to the Cytek Biosciences, Inc. fourth quarter 2025 earnings call. Earlier ...

FREMONT, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB), a leading cell analysis solutions company, is furthering its mission to advance the next generation ...

Cytek Biosciences, Inc. announced that it will report its financial results for the fourth quarter and full year 2024 on February 27, 2025, after market close. A conference call to discuss these ...

FREMONT, Calif., May 19, 2023 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the repurchase of ...

Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell ...

Fremont, CA-based Cytek Biosciences opened a new 50,000 ft 2 facility in Wuxi, China. The facility offers the advantage of fostering unique vendor relationships and further facilitates Cytek to ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded ...

FREMONT, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results ...